| Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo C Vergara, S Houben, V Suain, Z Yilmaz, R De Decker, V Vanden Dries, ... Acta neuropathologica 137, 397-412, 2019 | 88 | 2019 |
| Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions … K Ando, K Tomimura, V Sazdovitch, V Suain, Z Yilmaz, M Authelet, ... Neurobiology of disease 94, 32-43, 2016 | 66 | 2016 |
| iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology A Matamoros-Angles, LM Gayosso, Y Richaud-Patin, A Di Domenico, ... Molecular neurobiology 55, 3033-3048, 2018 | 46 | 2018 |
| Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution C Vergara, L Ordóñez-Gutiérrez, F Wandosell, I Ferrer, JA Del Rio, ... Molecular neurobiology 51, 1206-1220, 2015 | 45 | 2015 |
| PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia L Rodríguez-Pascau, E Britti, P Calap-Quintana, YN Dong, C Vergara, ... Neurobiology of Disease 148, 105162, 2021 | 37 | 2021 |
| Picalm reduction exacerbates tau pathology in a murine tauopathy model K Ando, R De Decker, C Vergara, Z Yilmaz, S Mansour, V Suain, ... Acta Neuropathologica 139, 773-789, 2020 | 33 | 2020 |
| Neurotoxicity of prion peptides mimicking the central domain of the cellular prion protein S Vilches, C Vergara, O Nicolas, G Sanclimens, S Merino, S Varon, ... PloS one 8 (8), e70881, 2013 | 31 | 2013 |
| Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice L Ordóñez-Gutiérrez, JM Torres, R Gavín, M Antón, AI Arroba-Espinosa, ... Neurobiology of aging 34 (12), 2793-2804, 2013 | 26 | 2013 |
| Domain-specific activation of death-associated intracellular signalling cascades by the cellular prion protein in neuroblastoma cells S Vilches, C Vergara, O Nicolás, Á Mata, JA Del Río, R Gavín Molecular neurobiology 53, 4438-4448, 2016 | 12 | 2016 |
| Tau protein as a new regulator of cellular prion protein transcription L Lidón, C Vergara, I Ferrer, F Hernández, J Ávila, JA Del Rio, R Gavín Molecular neurobiology 57 (10), 4170-4186, 2020 | 10 | 2020 |
| A 4R tauopathy develops without amyloid deposits in aged cat brains L Poncelet, K Ando, C Vergara, S Mansour, V Suain, Z Yilmaz, A Reygel, ... Neurobiology of aging 81, 200-212, 2019 | 10 | 2019 |
| Development of PPARγ agonists for the treatment of neuroinflammatory and neurodegenerative diseases: leriglitazone as a promising candidate P Pizcueta, C Vergara, M Emanuele, A Vilalta, L Rodríguez-Pascau, ... International Journal of Molecular Sciences 24 (4), 3201, 2023 | 8 | 2023 |
| Ten priorities for national brain and mental health plans F Mauguière, JL Trejo, P Andjus, C Vergara, R Pochet Croatian medical journal 60 (2), 152, 2019 | 6 | 2019 |
| PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in HiPS-Derived Astrocytes P Santambrogio, A Cozzi, I Di Meo, C Cavestro, C Vergara, ... Pharmaceutics 15 (1), 202, 2023 | 4 | 2023 |
| PHF-tau propagation in the presence of Amyloid ß pathology C Vergara, S Houben, V Vanden Dries, Z Yilmaz, V Suain, R De Decker, ... Front. Aging Neurosci 8 (10.3389), 2016 | 2 | 2016 |
| Papel regulador de la proteína priónica celular en la enfermedad de Alzheimer y uso de gamma-péptidos como potenciales agentes terapéuticos C Vergara Paños Universitat de Barcelona, 2015 | 2 | 2015 |
| MIN-102 enhance the oxidative profile of FRDA mouse model T Lapena-Luzon, N Beneto, L Rodriguez-Pascau, P Pizcueta, C Vergara, ... FEBS OPEN BIO 12, 127-127, 2022 | | 2022 |
| Aged cats: a naturally occuring model of tauopathy. L Poncelet, K Ando, C Vergara, E Gilissen, Z Yilmaz, S Mansour, JP Brion, ... | | 2019 |
| Picalm susceptibility RS3851179 locus for late onset Alzheimer's disease affects the levels of its mRNA and protein expression in human. K Ando, G Pregoni, J Verheijen, C Vergara Panos, R De Decker, ... | | 2019 |
| Amyloid pathology enhances seeding and propagation of fibrillar endogenous non-mutant tau in vivo through p25/CDK5 activation. C Vergara Panos, S Houben, V Suain, Z Yilmaz, R De Decker, ... | | 2019 |
